Received Mar 18, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TYP | TYPHOID LIVE ORAL TY21A (VIVOTIF) | BERNA BIOTECH, LTD. | 1 | Unknown | PO / MO |
Patient took Vivotif with food; Case reference number US-BN-2025-001390 is a spontaneous case initially received from a consumer via Communication (reference number: USBAV25-1992) on 11-Aug-2025 and concerns a male patient of unknown age. The patient's medical history and concomitant medication details were not provided. On 11-Aug-2025, the patient took the first dose of Vivotif with food (batch number: unknown), at an unknown dose, orally at unknown site of administration for unknown indication (explicitly coded as 'drug administration error'). At the time of the initial report, the patient had not experienced any adverse effects. No further information was provided.; Reporter's Comments: A male patient of unknown age took the first dose of Vivotif with food for unknown indication, which is considered as drug administration error. The patient had not experienced any adverse effects. Product administration error is considered as listed per company convention. The patient's medical history and concomitant medication details were not provided. Product administration error is not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.; Sender's Comments: A male patient of unknown age took the first dose of Vivotif with food for unknown indication, which is considered as drug administration error. The patient had not experienced any adverse effects. Product administration error is considered as listed per company convention. The patient's medical history and concomitant medication details were not provided. Product administration error is not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.
Comments: none.